Nakamura, Ryuji published the artcileOral camostat mesilate administration on alkaline reflux esophagitis in an experimental animal model, Synthetic Route of 71079-09-9, the publication is Iwate Igaku Zasshi (1999), 50(Suppl.), 653-659, database is CAplus.
Following total gastrectomy and esophagojejunostomy in an end-to-side fashion, tabs of a synthetic proteinase inhibitor, camostat mesilate, were fed to 15 dogs via cervical esophagostomy. A 67% decrease in trypsin activity was observed in duodenal juice aspirated 30 min after administration. The suppression lasted 90 min. Administration of camostat 3 times per day for 2 wk (n = 5) failed to significantly improve erosive esophagitis noted by esophagoscopy, although a tendency of hemostasis of hemorrhagic erosion has been induced. In postoperative alk. reflux esophagitis, oral camostat administration alone is insufficient to protect the esophageal mucosa. Bile acid or other constituents of reflux must also be neutralized to improve the clin. condition.
Iwate Igaku Zasshi published new progress about 71079-09-9. 71079-09-9 belongs to catalysis-chemistry, auxiliary class Salt,Carboxylic acid,Carbamidine,Amine,Benzene,Ester,Protease,Ser/Thr Protease, name is 2-(4-((4-Guanidinobenzoyl)oxy)phenyl)acetic acid methanesulfonic acid salt, and the molecular formula is C17H19N3O7S, Synthetic Route of 71079-09-9.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia